INS and cancer: Although less commonly studied, androgen deprivation therapy [235], radiotherapy [236–238], and stem cell transplant [239], as well as chemotherapy in combination with radiotherapy [240], also appear to pose an increased risk of excess weight and impaired insulin sensitivity in cancer survivors.